Importantly, this and another GWAS study identified ORMDL, the mammalian form of ORM, which encodes for an enzyme upstream of CerS2 in the de novo pathway of ceramide synthesis [4], to be genome-wide significantly associated with the risk of asthma, a chronic airflow obstructive disease associated with airway inflammation. The gene discussed is CERS2; the disease is asthma.